{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T23:43:59Z","timestamp":1770767039576,"version":"3.50.0"},"reference-count":42,"publisher":"Georg Thieme Verlag KG","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thromb Haemost"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The prospective observational cohort study COMPASS-COVID-19 aimed to develop a risk assessment model for early identification of hospitalized COVID-19 patients at risk for worsening disease. Patients with confirmed COVID-19 (n\u2009=\u2009430) hospitalized between March 18 and April 21, 2020 were divided in derivation (n\u2009=\u2009310) and validation (n\u2009=\u2009120) cohorts. Two groups became evident: (1) good prognosis group (G-group) with patients hospitalized at the conventional COVID-19 ward and (2) Worsening disease group (W-group) with patients admitted to the intensive care unit (ICU) from the emergency departments. The study end point was disease worsening (acute respiratory failure, shock, myocardial dysfunction, bacterial or viral coinfections, and acute kidney injury) requiring ICU admission. All patients were routinely evaluated for full blood count, prothrombin time, fibrinogen, D-dimers, antithrombin (AT), and protein C activity. Data from the first hospitalization day at the conventional ward or the ICU were analyzed. Cardiovascular risk factors and comorbidities were routinely registered. Obesity, hypertension, diabetes and male gender, increased fibrinogen and D-dimers, thrombocytopenia, AT deficiency, lymphopenia, and an International Society on Thrombosis and Haemostasis (ISTH) score for compensated disseminated intravascular coagulation score (cDIC-ISTH) \u22655 were significant risk factors for worsening disease. The COMPASS-COVID-19 score was derived from multivariate analyses and includes obesity, gender, hemoglobin, lymphocyte, and the cDIC-ISTH score (including platelet count, prothrombin time, D-dimers, AT, and protein C levels). The score has a very good discriminating capacity to stratify patients at high and low risk for worsening disease, with an area under the receiver operating characteristic curve value of 0.77, a sensitivity of 81%, and a specificity of 60%. Application of the COMPASS-COVID-19 score at the validation cohort showed 96% sensitivity. The COMPASS-COVID-19 score is an accurate clinical decision-making tool for an easy identification of COVID-19 patients being at high risk for disease worsening.<\/jats:p>","DOI":"10.1055\/s-0040-1716544","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T23:14:58Z","timestamp":1600816498000},"page":"1680-1690","source":"Crossref","is-referenced-by-count":39,"title":["Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19"],"prefix":"10.1055","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2316-6348","authenticated-orcid":false,"given":"Grigoris T.","family":"Gerotziafas","sequence":"additional","affiliation":[{"name":"Research Group \"Cancer, Haemostasis and Angiogenesis,\" INSERM U938, Centre de Recherche Saint-Antoine, Institut Universitaire de Canc\u00e9rologie, Faculty of Medicine, Sorbonne University, Paris, France"},{"name":"Service d\u2019H\u00e9matologie Biologique H\u00f4pital Tenon, H\u00f4pitaux Universitaires de l\u2019Est Parisien, Assistance Publique H\u00f4pitaux de Paris, Facult\u00e9 de M\u00e9decine Sorbonne Universit\u00e9, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodoros N.","family":"Sergentanis","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillaume","family":"Voiriot","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Service de M\u00e9decine Intensive R\u00e9animation, H\u00f4pital Tenon, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludovic","family":"Lassel","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et Tropicales, H\u00f4pital Tenon, H\u00f4pitaux Universitaires de l'Est Parisien, Assistance Publique H\u00f4pitaux de Paris, Facult\u00e9 de M\u00e9decine Sorbonne Universit\u00e9, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chryssa","family":"Papageorgiou","sequence":"additional","affiliation":[{"name":"Service Anesth\u00e9sie, R\u00e9animation et M\u00e9decine P\u00e9riop\u00e9ratoire, H\u00f4pital Tenon, H\u00f4pitaux Universitaires de l'Est Parisien, Assistance Publique H\u00f4pitaux de Paris, Facult\u00e9 de M\u00e9decine Sorbonne Universit\u00e9, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre","family":"Elabbadi","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Service de M\u00e9decine Intensive R\u00e9animation, H\u00f4pital Tenon, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthieu","family":"Turpin","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Service de M\u00e9decine Intensive R\u00e9animation, H\u00f4pital Tenon, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Vandreden","sequence":"additional","affiliation":[{"name":"Clinical Research Department, Diagnostica Stago, Gennevilliers, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loula","family":"Papageorgiou","sequence":"additional","affiliation":[{"name":"Research Group \"Cancer, Haemostasis and Angiogenesis,\" INSERM U938, Centre de Recherche Saint-Antoine, Institut Universitaire de Canc\u00e9rologie, Faculty of Medicine, Sorbonne University, Paris, France"},{"name":"Service d\u2019H\u00e9matologie Biologique H\u00f4pital Tenon, H\u00f4pitaux Universitaires de l\u2019Est Parisien, Assistance Publique H\u00f4pitaux de Paris, Facult\u00e9 de M\u00e9decine Sorbonne Universit\u00e9, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodora","family":"Psaltopoulou","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelos","family":"Terpos","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meletios-Athanasios","family":"Dimopoulos","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine","family":"Parrot","sequence":"additional","affiliation":[{"name":"Service de pneumologie, H\u00f4pital Tenon, H\u00f4pitaux Universitaires de l'Est Parisien, Assistance Publique H\u00f4pitaux de Paris, Facult\u00e9 de M\u00e9decine Sorbonne Universit\u00e9, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Cadranel","sequence":"additional","affiliation":[{"name":"Service de pneumologie, H\u00f4pital Tenon, H\u00f4pitaux Universitaires de l'Est Parisien, Assistance Publique H\u00f4pitaux de Paris, Facult\u00e9 de M\u00e9decine Sorbonne Universit\u00e9, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilles","family":"Pialoux","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et Tropicales, H\u00f4pital Tenon, H\u00f4pitaux Universitaires de l'Est Parisien, Assistance Publique H\u00f4pitaux de Paris, Facult\u00e9 de M\u00e9decine Sorbonne Universit\u00e9, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Fartoukh","sequence":"additional","affiliation":[{"name":"Sorbonne Universit\u00e9, Service de M\u00e9decine Intensive R\u00e9animation, H\u00f4pital Tenon, Assistance Publique - H\u00f4pitaux de Paris, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ismail","family":"Elalamy","sequence":"additional","affiliation":[{"name":"Research Group \"Cancer, Haemostasis and Angiogenesis,\" INSERM U938, Centre de Recherche Saint-Antoine, Institut Universitaire de Canc\u00e9rologie, Faculty of Medicine, Sorbonne University, Paris, France"},{"name":"Service d\u2019H\u00e9matologie Biologique H\u00f4pital Tenon, H\u00f4pitaux Universitaires de l\u2019Est Parisien, Assistance Publique H\u00f4pitaux de Paris, Facult\u00e9 de M\u00e9decine Sorbonne Universit\u00e9, Paris, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"F Wu","year":"2020","journal-title":"Nature"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"R Lu","year":"2020","journal-title":"Lancet"},{"issue":"07","key":"ref3","doi-asserted-by":"crossref","first-page":"e00127-20","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Y Wan","year":"2020","journal-title":"J Virol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"C Huang","year":"2020","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"N Chen","year":"2020","journal-title":"Lancet"},{"issue":"18","key":"ref6","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic","volume":"75","author":"E Driggin","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"06","key":"ref7","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S2468-1253(20)30084-4","article-title":"COVID-19 and the liver: little cause for concern","volume":"5","author":"M N Bangash","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"P Mehta","year":"2020","journal-title":"Lancet"},{"issue":"23","key":"ref9","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"B Bikdeli","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/jth.14810","article-title":"ISTH interim guidance on recognition and management of coagulopathy in COVID-19","volume":"18","author":"J Thachil","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"05","key":"ref11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/bjh.16727","article-title":"Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action","volume":"189","author":"A Kollias","year":"2020","journal-title":"Br J Haematol"},{"issue":"18","key":"ref12","first-page":"1775","article-title":"Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy","volume":"323","author":"G Onder","year":"2020","journal-title":"JAMA"},{"issue":"18","key":"ref13","first-page":"1839","article-title":"Management of critically ill adults with COVID-19","volume":"323","author":"J T Poston","year":"2020","journal-title":"JAMA"},{"issue":"07","key":"ref14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/ajh.25829","article-title":"Hematological findings and complications of COVID-19","volume":"95","author":"E Terpos","year":"2020","journal-title":"Am J Hematol"},{"issue":"01","key":"ref15","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jaci.2020.04.006","article-title":"Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan","volume":"146","author":"X Li","year":"2020","journal-title":"J Allergy Clin Immunol"},{"issue":"05","key":"ref16","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S2213-2600(20)30161-2","article-title":"Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations","volume":"8","author":"J Phua","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"19","key":"ref17","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"B Cao","year":"2020","journal-title":"N Engl J Med"},{"issue":"16","key":"ref18","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically ill patients with COVID-19 with convalescent plasma","volume":"323","author":"C Shen","year":"2020","journal-title":"JAMA"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jclinepi.2020.04.016","article-title":"COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine\/hydroxychloroquine","volume":"123","author":"P E Alexander","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"19","key":"ref20","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMe2005477","article-title":"Covid-19\u2013the search for effective therapy","volume":"382","author":"L R Baden","year":"2020","journal-title":"N Engl J Med"},{"issue":"24","key":"ref21","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1056\/NEJMoa2007016","article-title":"Compassionate use of remdesivir for patients with severe Covid-19","volume":"382","author":"J Grein","year":"2020","journal-title":"N Engl J Med"},{"issue":"01","key":"ref22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1148\/radiol.2020201365","article-title":"The role of chest imaging in patient management during the COVID-19 Pandemic: a multinational consensus statement from the Fleischner Society","volume":"296","author":"G D Rubin","year":"2020","journal-title":"Radiology"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"F B Taylor","year":"2001","journal-title":"Thromb Haemost"},{"issue":"S 01","key":"ref24","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jth.12262","article-title":"Diagnostic and prognostic prediction models","volume":"11","author":"J M Hendriksen","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"04","key":"ref25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"F E Harrell Jr","year":"1996","journal-title":"Stat Med"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"P Peduzzi","year":"1996","journal-title":"J Clin Epidemiol"},{"issue":"04","key":"ref27","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia","volume":"18","author":"N Tang","year":"2020","journal-title":"J Thromb Haemost"},{"issue":"07","key":"ref28","first-page":"1","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China","volume":"180","author":"C Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(20)30937-5","article-title":"Endothelial cell infection and endotheliitis in COVID-19","volume":"395","author":"Z Varga","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"ref30","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1164\/rccm.202003-0543OC","article-title":"Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study","volume":"201","author":"Y Du","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"issue":"08","key":"ref31","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1055\/s-0040-1712097","article-title":"Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified?","volume":"120","author":"M Cattaneo","year":"2020","journal-title":"Thromb Haemost"},{"issue":"01","key":"ref32","first-page":"W1-73","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"K GM Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"m1328","DOI":"10.1136\/bmj.m1328","article-title":"Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal","volume":"369","author":"L Wynants","year":"2020","journal-title":"BMJ"},{"issue":"20","key":"ref34","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City Area","volume":"323","author":"S Richardson","year":"2020","journal-title":"JAMA"},{"issue":"15","key":"ref35","doi-asserted-by":"crossref","first-page":"458","DOI":"10.15585\/mmwr.mm6915e3","article-title":"Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1-30, 2020","volume":"69","author":"S Garg","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.jinf.2020.04.021","article-title":"Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis","volume":"81","author":"Z Zheng","year":"2020","journal-title":"J Infect"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e102","DOI":"10.1056\/NEJMoa2007621","article-title":"Cardiovascular disease, drug therapy, and mortality in Covid-19","volume":"382","author":"M R Mehra","year":"2020","journal-title":"N Engl J Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.32388\/WPP19W.3","article-title":"Low incidence of daily active tobacco smoking in patients with symptomatic COVID-19","author":"M Miyara","year":"2020","journal-title":"Qeios"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.20.20037325","article-title":"Predicting COVID-19 malignant progression with AI techniques","author":"X Bai","year":"2020","journal-title":"medRxiv"},{"issue":"15","key":"ref40","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/cid\/ciaa443","article-title":"A tool for early prediction of severe coronavirus disease 2019 (COVID-19): a multicenter study using the risk nomogram in Wuhan and Guangdong, China","volume":"71","author":"J Gong","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"06","key":"ref41","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3760\/cma.j.issn.0366-6999.20123102","article-title":"Weighted Youden index and its two-independent-sample comparison based on weighted sensitivity and specificity","volume":"126","author":"D L Li","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"P1569","DOI":"10.1016\/S0140-6736(20)31022-9","article-title":"Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"395","author":"Y Wang","year":"2020","journal-title":"Lancet"}],"container-title":["Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0040-1716544.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T15:15:36Z","timestamp":1723648536000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0040-1716544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":42,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,23]]},"published-print":{"date-parts":[[2020,12]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0040-1716544","relation":{},"ISSN":["0340-6245","2567-689X"],"issn-type":[{"value":"0340-6245","type":"print"},{"value":"2567-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]}}}